Pershing Square

The torrid October, with its historic S&P500 point rally, is finally in the history books, and at least for a select group of hedge funds such as Glenview, Pershing Square and Greenlight and certainly their L.P.s, a very scary Halloween couldn't come fast enough, leading to losses between 15% and 20%. How did everyone else fare? Below, courtesy of Deutsche Bank's Jim Reid, is a summary of what worked in October (and YTD), and what didn't.

“I hope Bill Ackman has done more research on Valeant than he did on Herbalife, Target, Borders and JC Penny,” said Alan Hoffman, executive vice president, global corporate affairs, Herbalife.

Based on the overnight market prints which are an oddly reddish shade of green, it took algos about 12 hours to realize that the reason they soared for most of October, namely hopes of an easier Fed which were launched with the terrible September jobs report and continued with increasingly worse US economic report in the past month, can not be the same reason they also soared yesterday after the announcement of a more hawkish than expected Fed statement which envisioned a stronger US economy and a removal of foreign considerations, which even more curiously took place on even worse data than the Fed's far more dovish September statement.

It's been a tough week for Pershing Square and Bill Ackman. First, Valeant gets eviscerated; and now, another major holding - Platform Specialty Products - plunged as much as 15% on news that the CEO is retiring.

As always happens after shocking events like yesterday which "nobody could have possibly predicted", watching the Penguin gallery reel in its humiliation is absolutely worth the price of admission.

• ECB Haunted by Paradox as Draghi Weighs Risk of QE Signaling (BBG)
• At odds with Republicans, Hillary Clinton to testify on Benghazi (Reuters)
• House tees up conservative plans to raise debt limit (Hill)
• U.S., Russia to Meet at Syria Conference to Discuss Crisis (WSJ)
• Putin Gains Record Support Among Russians Over Syria, Poll Shows (BBG)
• China Plans 2020 Deadline for Dismantling Capital Controls (BBG)
• Nyrstar Drops the Most on Record as Mining Hit by Metal Rout (BBG)

"As you know, the environment for global macro fundamentals-based trading continues to be challenging. That factor, combined with the lack of certainty over when a recovery will take hold, led us to conclude that the time was right to return capital to you."

It has been a cruel summer, with lots of leverage, for Bill Ackman and his Pershing Square hedge fund.

In August, hedge funds blamed risk-parity funds for their dramatic underperformance. In September, the underperformance continued however this time, with risk-parity funds supposedly buying stocks, one can't blame them. To be sure, some such as Ackman whose 20 million shares of Valeant are hurting badly, will blame the Martin Shkrelis of the world for the biggest biotech tumble in years, but others may have to bite the bullet and admit it is their own lack of ability to come up with alpha in a centrally-planned "market" that is the reason.

• After Rough Quarter, Investors Buckle Up (WSJ)
• From heroes to bystanders? Central banks' growth challenge (Reuters)
• Russian Airstrike in Syria Targeted CIA-Backed Rebels, U.S. Officials Say (WSJ)
• Kremlin says Syria air strikes target list of groups, not just Islamic State (Reuters)
• That’s information warfare? Russia accused of killing civilians in Syria (RT)
• Euro zone factory growth eases in August despite modest price rises (Reuters)
• How Glencore's Crazy Month Makes Greek Banks Look Tame (BBG)

"In the Twitter-storm furor over Turing’s recent one-drug price gouge attempt, the media has overlooked the reality that Martin Shkreli was created by the system. Shkreli is merely a rogue trying to play the gambit that Valeant has perfected." And there you have it: boost the prices of dozens of drugs in the span of 1-3 years anywhere between 100% and 800% and nobody notices (thank you insurance companies). But hike the price of one drug by 5,500% and suddenly all of America thinks you are satan incarnate.

News That Matters

You can't say Nassim Taleb didn't warn you: the outspoken academic-philosopher, best known for his prediction that six sigma "fat tail", or black swan, events happen much more frequently than they should statistically (perhaps a main reason why there is no longer a market but a centrally-planned cesspool of academic intervention) just had a black swan land smack in the middle of the Universa hedge fund founded by ardent Ron Paul supporter Mark Spitznagel, and affiliated with Nassim Taleb. The result: a $1 billion payday, translating into a 20% YTD return, in a week when the VIX exploded from the teens to over 50, and which most other hedge funds would love to forget.

• Virginia TV journalists killed by suspect with 'powder keg' of anger (Reuters)
• Policeman shot to death and three women stabbed, one fatally, in Louisiana (Reuters)
• China Intervened Today to Shore Up Stocks Ahead of Military Parade (Reuters)
• Margin Calls Bite Investors, Banks (WSJ)
• "Computer glitch" is preventing dozens of mutual funds, ETFs from promptly pricing their securities (WSJ)
• Oil prices rise more than 4 percent as equities rally (Reuters)
• Oil Industry Needs Half a Trillion Dollars to Endure Price Slump (BBG)